Cantitate/Preț
Produs

Stem Cells and Neurodegenerative Diseases

Editat de Laurent Lescaudron, Julien Rossignol, Gary L. Dunbar
en Limba Engleză Hardback – 17 mar 2014
This book explores the potentiel of stem cells for ameliorating the quality of life of patients with neurological and neurodegenerative diseases. It discusses results of pre-clinical investigations and case studies on the effects of stem cell transplantation on cell death, to promote/stimulate neuroprotection after brain and spinal cord injury through trophic support, cell replacement and remyelination. It covers the maintenance of the balance between stem cells and their progenitors within their niche, both under normal and degenerative processes, ischemic stroke, multiple sclerosis, and brain tumor.
Citește tot Restrânge

Preț: 93692 lei

Preț vechi: 114070 lei
-18% Nou

Puncte Express: 1405

Preț estimativ în valută:
17930 18498$ 15175£

Carte tipărită la comandă

Livrare economică 05-19 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781482210736
ISBN-10: 1482210738
Pagini: 244
Ilustrații: 8 black & white illustrations, 11 colour illustrations
Dimensiuni: 156 x 234 x 25 mm
Greutate: 0.48 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States

Cuprins

Stem Cells as a Source for Cell Therapy in Parkinson's Disease. The use of stem cells in treating Huntington’s disease: state of research and prospects for future treatments. Stem Cell Transplantation Strategies After Spinal Cord Injury. Role of endogenous neural precursor cells in Multiple Sclerosis. Stem cells and Alzheimer’s disease. Cell Therapies for Ischemic Stroke. Immune response to intracerebral transplantation: particular properties of stem cells. Glioma stem cells: the brain behind the tumor? The future of induced pluripotent stem cells in brain regenerative medicine.

Notă biografică

Lescaudron, Laurent; Rossignol, Julien; Dunbar, Gary L.

Descriere

This book explores the potential of stem cells for ameliorating the quality of life of patients with neurological and neurodegenerative diseases